From https://projects.propublica.org/docdollars. © Copyright 2013 Pro Publica Inc.
Cephalon
Cephalon, acquired in 2011 by Israeli-based Teva Pharmaceutical Industries Ltd., agreed to pay a $425 million settlement in 2008 for marketing Actiq, Gabitril, and Provigil for uses not approved by the Food and Drug Administration.
Cephalon started reporting payments to physicians as of the beginning of 2009. In the first year, it aggregated payments for consulting and speaking into one amount. Subsequently, the company broke out payments for speaking, consulting, educational items, meals, research and travel.
The company removed payment information from its website in January 2014, after its Corporate Integrity Agreement with the U.S. Department of Health and Human Services inspector general expired in September 2013. Dollars for Docs includes payments disclosed through the second quarter of 2013.
Notable drugs
- Treanda (chronic lymphocytic leukemia and indolent B-cell non-Hodgkin’s lymphoma)
- Nuvigil (excessive sleepiness associated with narcolepsy, obstructive sleep apnea and shift work disorder)
- Gabitril (partial seizures)
- Fentora (breakthrough pain for patients with cancer)
- Actiq (breakthrough pain for patients with cancer)
- Amrix (muscle spasm)
Payment Reports
2009 Jan. to Dec.
Avg. Quarterly | Total | |
---|---|---|
Combination | $2,313,404 | $9,253,617 |
$2,313,404 | $9,253,617 |
2010 Jan. to Dec.
Avg. Quarterly | Total | |
---|---|---|
Research | $3,127,411 | $12,509,646 |
Speaking | $1,062,270 | $4,249,080 |
Meals | $596,499 | $2,385,996 |
Travel | $276,660 | $1,106,639 |
Consulting | $178,735 | $714,942 |
Items, Gifts | $47,034 | $188,136 |
$5,288,610 | $21,154,439 |
2011 Jan. to Dec.
Avg. Quarterly | Total | |
---|---|---|
Research | $6,011,451 | $24,045,803 |
Speaking | $899,763 | $3,599,050 |
Meals | $401,466 | $1,605,865 |
Travel | $258,399 | $1,033,595 |
Consulting | $252,525 | $1,010,101 |
Items, Gifts | $43,780 | $175,120 |
$7,867,384 | $31,469,535 |
2012 Jan. to Dec.
Avg. Quarterly | Total | |
---|---|---|
Research | $4,445,012 | $17,780,050 |
Consulting | $918,895 | $3,675,581 |
Speaking | $804,175 | $3,216,700 |
Meals | $463,890 | $1,855,558 |
Travel | $235,373 | $941,490 |
Items, Gifts | $66,644 | $266,576 |
$6,933,989 | $27,735,955 |
2013 Jan. to June
Avg. Quarterly | Total | |
---|---|---|
Research | $2,491,225 | $4,982,450 |
Speaking | $1,203,425 | $2,406,850 |
Consulting | $761,312 | $1,522,624 |
Meals | $283,177 | $566,354 |
Travel | $268,759 | $537,519 |
Items, Gifts | $1,000 | $2,000 |
$5,008,898 | $10,017,796 |
Total Payments by State
State | Total |
---|---|
California | $13,909,842 |
Texas | $12,556,090 |
Florida | $8,048,348 |
New York | $5,975,328 |
Pennsylvania | $4,544,596 |
Ohio | $4,214,580 |
Maryland | $3,429,402 |
Utah | $3,384,742 |
Georgia | $3,368,586 |
North Carolina | $3,097,049 |
New Jersey | $2,840,144 |
South Carolina | $2,475,805 |
Illinois | $2,354,937 |
Colorado | $2,201,661 |
Indiana | $2,019,702 |
Missouri | $1,993,587 |
Tennessee | $1,853,920 |
Washington | $1,640,399 |
Oklahoma | $1,505,278 |
Alabama | $1,491,864 |
Virginia | $1,487,168 |
Michigan | $1,342,932 |
Massachusetts | $1,240,623 |
Minnesota | $1,096,113 |
District of Columbia | $1,035,745 |
Arizona | $1,019,626 |
Louisiana | $991,740 |
Kansas | $952,787 |
Kentucky | $873,393 |
Wisconsin | $779,834 |
Oregon | $731,301 |
Nevada | $598,950 |
Rhode Island | $564,635 |
Connecticut | $517,217 |
[Unknown State] | $495,461 |
Nebraska | $428,025 |
Arkansas | $403,623 |
Idaho | $326,282 |
Mississippi | $308,870 |
West Virginia | $306,945 |
New Hampshire | $260,166 |
Iowa | $218,526 |
New Mexico | $193,045 |
Delaware | $174,693 |
Maine | $110,724 |
Montana | $97,773 |
North Dakota | $52,731 |
Hawaii | $28,679 |
Alaska | $25,747 |
Puerto Rico | $18,635 |
South Dakota | $17,382 |
Vermont | $13,904 |
Wyoming | $12,188 |
What Companies Disclose
See which services pharmaceutical companies report paying health practitioners for.
Big Pharma’s Big Fines
Drug companies have paid billions to the Department of Justice to resolve allegations of health care fraud. See some of the biggest settlements.